SCHEMBL7657788

SCHEMBL7657788

NC(=NO)c1ccc(NC(=O)c2ccccc2-c2ccccc2C(=O)NO)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
ALDH1A1 P00352 1/20 0.53
TP53 P04637 1/20 0.53
HPGD P15428 1/20 0.53
USP2 O75604 1/20 0.52
POLB P06746 1/20 0.52
GFER P55789 1/20 0.52
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
ALOX12 P18054 1/20 0.50
HDAC2 Q92769 6/20 0.47
HDAC1 Q13547 5/20 0.47
PLAU P00749 3/20 0.47
F10 P00742 3/20 0.47
PLAT P00750 2/20 0.47
F2 P00734 2/20 0.47
PLG P00747 1/20 0.47
CHRNB2 P17787 1/20 0.47
CHRNB4 P30926 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7662470 0.99 NPC1 (0.52) NPC1RAB9AALDH1A1TP53HPGD
SCHEMBL7657710 0.89 CYP2C9 (0.66) NPC1RAB9AALDH1A1TP53HPGD
Hydrochloric Acid SCHEMBL7656984 0.88 CYP2C9 (0.64) NPC1RAB9AALDH1A1TP53HPGD
SCHEMBL7653539 0.83 PLAU (0.68) CYP3A4CYP2C9ALOX12PLAUF10
SCHEMBL7654193 0.80 SMN1; SMN2 (0.50) NPC1RAB9AALDH1A1TP53CYP3A4
SCHEMBL7657919 0.75 F3 (0.79) F10F2PLGPRSS1PRSS2
SCHEMBL7652151 0.75 F10 (0.65) PLAUF10PLATF2PLG
SCHEMBL7661279 0.75 PLAU (0.62) PLAUF10PLATF2PLG
SCHEMBL3026631 0.73 GAA (0.64) ALDH1A1CYP3A4CYP2C9ALOX12HDAC2
SCHEMBL7661930 0.72 CYP3A4 (0.69) CYP3A4CYP2C9ALOX12PLAUF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US claimed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP claimed